3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter /financial year ended March 31, 2025 and to discuss the matter of recommendation of dividend, if any, for the financial year ended March 31 , 2025